Pro Medicus Limited (OTCMKTS:PMCUF – Get Free Report)’s share price gapped down prior to trading on Wednesday. The stock had previously closed at $118.12, but opened at $114.05. Pro Medicus shares last traded at $114.05, with a volume of 14 shares.
Analysts Set New Price Targets
Separately, Jefferies Financial Group cut Pro Medicus from a “buy” rating to a “hold” rating in a research report on Wednesday, July 8th. One research analyst has rated the stock with a Hold rating, According to MarketBeat, Pro Medicus currently has a consensus rating of “Hold” and an average price target of $155.00.
Check Out Our Latest Stock Report on Pro Medicus
Pro Medicus Price Performance
About Pro Medicus
Pro Medicus Limited is an Australian medical technology company that develops software for medical imaging and healthcare organizations. Its primary product is the Visage enterprise imaging platform, which supports the storage, management, viewing and distribution of diagnostic images such as X-rays, CT scans and magnetic resonance images.
The company’s software is designed to help hospitals, radiology practices and other healthcare providers manage imaging workflows and enable clinicians to access diagnostic information across locations.
Recommended Stories
- Five stocks we like better than Pro Medicus
- Inhibrx’s Insider Buying Adds Fuel to a High-Short-Interest Biotech Setup
- Alamos Gold’s 1 Million-Ounce Growth Story Is Hiding in Plain Sight
- Everyone in AI Is Quietly Copying Palantir’s Playbook
- Advanced Micro Devices Is Spending $8.2 Billion to Learn What AI Needs Next
Receive News & Ratings for Pro Medicus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pro Medicus and related companies with MarketBeat.com's FREE daily email newsletter.
